CGEN — Compugen

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Compugen

Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe. The company's pipeline consists of COM701, an immuno-oncology pipeline program with an anti-PVRIG antibody; COM902, a therapeutic anti-TIGIT antibody, are in Phase 1 clinical trials and have been evaluated for the treatment of sol… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$2.78
Market Cap$247M
Float92.4M
Shares Outstanding94.6M
P/E (Forward)12.36
P/E (TTM)6.87
Price/Sales (TTM)3.40
vs. Analyst Target+123.0% to analyst PT
Profit Margin47.97%
Operating Margin (TTM)-414.38%
Revenue (TTM)$72.7M
Dividend RateNone
Analyst Target Price$6.20 (4 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $2.0M -$27.3M $1.9M -$30.8M
2021 $6.0M -$32.9M $5.3M -$34.6M
2022 $7.5M -$33.7M $6.5M -$34.9M
2023 $33.5M -$18.8M $31.5M -$12.5M
2024 $27.9M -$14.2M $19.9M -$14.4M
2025 $72.8M $35.3M $63.5M $31.8M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $1.3M -$7.3M
Sep 2025 $1.9M -$7.0M
Dec 2025 $67.3M $56.8M
Mar 2026 $2.2M -$7.7M

Ownership & Float

Insider Ownership2.1%
Institutional Ownership15.2%
Short Float1.5%
% of All Funds Holding0.86%
Number of Funds Holding71

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$2.67Near-term / short-term trend
Weekly40-Week SMA$1.95Medium-term trend
Weekly80-Week SMA$1.80Cyclical trend (business cycle)
Weekly200-Week SMA$1.54Secular trend (multi-year)
Monthly10-Month SMA$1.90Near-term monthly trend
Monthly20-Month SMA$1.78Medium-term monthly trend
Monthly40-Month SMA$1.64Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$2.20 support 1.50x 0 months ago
$1.50 support 1.62x 6 months ago

Historical Earnings Reactions (103 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.63% 0.28% 51.46% 42.31% -8.56%
1 Day -0.16% -0.67% 42.72% 44.51% -11.11%
1 Week -0.55% -0.21% 46.60% 51.65% -38.27%
2 Weeks 0.95% -1.46% 40.20% 62.45% -32.10%
1 Month -0.11% -2.05% 40.20% 80.77% -39.51%

Next earnings: August 6, 2026 (68 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan15.7%76.9%26
Feb-4.4%30.8%26
Mar-2.1%42.3%26
Apr6.2%50.0%26
May1.2%40.0%25
Jun1.4%40.0%25
Jul-3.0%40.0%25
Aug3.4%52.0%25
Sep-3.9%42.3%26
Oct-0.8%34.6%26
Nov-3.4%46.2%26
Dec10.7%42.3%26

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.18% 40.6% 1216
Tuesday 0.30% 44.3% 1332
Wednesday 0.04% 46.1% 1330
Thursday 0.05% 43.1% 1304
Friday 0.22% 48.1% 1301

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 15.2%

Insider Transactions — Smart Summary

Total insider ownership: 2.1%

12-Month Insider Activity Summary

Total Filings10
Net Value-$77,661.413
Net Shares Change0
% of Float0.0%
C-Suite Filings10
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
Levine Zurit SVP, Business Development -$47,683.475 7 N/A
Ophir Eran President and CEO -$29,977.938 3 N/A

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-04-27 Ophir Eran President and CEO -$11,854.5 Transaction at $2.01, now +38.0%
2026-04-27 Levine Zurit SVP, Business Development -$4,100 Transaction at $2.17, now +27.8%
2026-04-15 Ophir Eran President and CEO -$10,375 Transaction at $1.87, now +48.9%
2026-04-15 Levine Zurit SVP, Business Development -$3,300 Transaction at $1.97, now +40.8%
2026-04-15 Levine Zurit SVP, Business Development -$4,779.688 Transaction at $1.80, now +54.5%
2026-04-13 Levine Zurit SVP, Business Development -$4,779.688 Transaction at $1.80, now +54.5%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Compugen (CGEN) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for CGEN on Trend Edge →